BRWA
KZIA

B. Riley Wealth Advisors’s Kazia Therapeutics KZIA Stock Holding History

B. Riley Wealth Advisors’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-16
Closed -$11.8K – 1326
2014
Q2 		$11.8K Buy
+16
New +$12.3K ﹤0.01% 1713

Other funds holding KZIA

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

B. Riley Wealth Advisors's KZIA Position: Q3 2014 in Review

B. Riley Wealth Advisors sold out of Kazia Therapeutics (KZIA) in Q3 2014, closing a stake of 16 shares — an estimated $11.8K sold.

B. Riley Wealth Advisors first reported a position in KZIA in Q2 2014 and held it in 1 quarter. The position peaked at $11.8K in Q2 2014. 5 funds tracked by Wall St. Rank hold KZIA as of Q3 2014.

  • B. Riley Wealth Advisors reported no remaining Kazia Therapeutics position as of Q3 2014 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 16 Kazia Therapeutics shares in Q3 2014, an estimated $11.8K.
  • B. Riley Wealth Advisors first reported a position in Kazia Therapeutics in Q2 2014 and held it in 1 quarter.
  • B. Riley Wealth Advisors's Kazia Therapeutics position peaked at $11.8K in Q2 2014.
  • 5 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q3 2014.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.